More cancer-killing gold found in gold nanoparticles?

The value of gold seems to rising in the war on cancer. Last month there were reports that a group at the Georgia Institute of Technology showed in lab tests that gold nanoparticles were able to slip into the nuclei of cancer cells and trigger a cellular death process known as apoptosis. More recently, scientists at Syracuse University say that they have engineered gold nanoparticles with attached DNA that binds to the chemotherapy drug doxorubicin, aiming to improve delivery of the drug to tumors while avoiding healthy tissues. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.